2013
DOI: 10.1016/j.jconrel.2013.05.031
|View full text |Cite
|
Sign up to set email alerts
|

Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(27 citation statements)
references
References 35 publications
1
26
0
Order By: Relevance
“…The screening of a large library of chemicals and chemical mixtures to identify compositions that enhance the uptake of peptides and proteins 120 led to the identification of the zwitterionic surfactant dimethyl palmitoyl ammonio propanesulphonate (PPS), which enhanced the intestinal permeation of calcitonin in mice 121 . Other methods of increasing absorption include pH-sensitive hydrogels to protect the drug from low pH in the stomach 122 , chitosans 123 and chitosan derivatives 124 to induce mucoadhesion of the drug carrier and increase intestinal permeation, and acrylate-based polymers to increase mucoadhesion 125 .…”
Section: Alternative Routes Of Drug Deliverymentioning
confidence: 99%
“…The screening of a large library of chemicals and chemical mixtures to identify compositions that enhance the uptake of peptides and proteins 120 led to the identification of the zwitterionic surfactant dimethyl palmitoyl ammonio propanesulphonate (PPS), which enhanced the intestinal permeation of calcitonin in mice 121 . Other methods of increasing absorption include pH-sensitive hydrogels to protect the drug from low pH in the stomach 122 , chitosans 123 and chitosan derivatives 124 to induce mucoadhesion of the drug carrier and increase intestinal permeation, and acrylate-based polymers to increase mucoadhesion 125 .…”
Section: Alternative Routes Of Drug Deliverymentioning
confidence: 99%
“…Among these materials, chitosan has been highly utilized in a number of oral drug delivery systems, including chitosan-based micro- and nanoparticulate drug delivery systems [8994], chitosan-drug conjugates [95, 96], and chitosan macroscale patches [97, 98]. Chitosan is an attractive material for micro/nanofabricated platforms as it is compatible with a number of microfabrication approaches [99, 100], is stable through pH values relevant to GI physiology [101], and has been utilized in microfabricated oral drug delivery systems [58, 102].…”
Section: Strategies To Increase Micro/nanofabricated Oral Drug Delmentioning
confidence: 99%
“…Significant difference from negative physiological saline control (*p50.05; **p50.01) (Xiong et al, 2013). tract is necessary, especially when mucoadhesive systems were used to prolong the residence time (Wong, 2010). Furthermore, potential insulin alternatives, such as psyllium polysaccharides (Singh & Chauhan, 2009), chalcone (Hsieh et al, 2012), glucagon-like peptide-1 (Ahn et al, 2013), can be added to the oral dosage form in order to avoid the risk of insulin overdose. A successful oral insulin delivery system should be biocompatible and biodegradable, keeping the stability of insulin during the absorption, and ultimately improving the bioavailability of insulin.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%